Shares of the company advanced following the news announcement as the following chart testifies.
Source: Reuters.com
But investors have to be careful with Chindex Int. (NASDAQ:CHDX) according to our findings. Here is why. The company reported revenues of $41.3 million for the first three months of 2010, a drop of 30.9% from same period last year. Net income for the quarter came out to $515,000 or $.04 per share, a significant drop from $3.4 million or $.22 per share a year ago.
While it may seem that the significant drop is attributed to a seasonably high basis back in 2009, the truth is that the company is unable to achieve a constant revenue and earnings growth.
Given that the stock price of Chindex International (NASDAQ:CHDX) more than doubled since June 2009 while earnings improved yet the company is just barely in the black, critics don't see much upside potential at this point. The company has to have at least two more sound quarters to regain investors' confidence.
June 11, 2010 (Chinavestor) Everything goes against China-Biotics Inc. (NASDAQ:CHBT), a Chinese health supplement products maker and distributor, this morning. The company missed quarterly revenue an...
June 9, 2010 (Chinavestor) Synutra International (NASDAQ:SYUT), a Chinese infant formula company, reported 2009 fourth quarter financials after the close on Wednesday. Total revenues for the fourth...
June 4, 2010 (Chinavestor) Shares of China Medical Technology (NASDAQ:CMED) surged $.90 or 8.87% to $10.92 after 40 minutes of trading on Friday as investors digest the latest numbers of the comp...
May 11, 2010 (Chinavestor) It is worth the effort to look revenue and earnings numbers from a perspective. American Oriental Bioengineering (NYSE:AOB) reported a 16.7% revenue increase from $46.1 ...
